Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anemia × ferric derisomaltose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Iron-Deficiency 2 Anemia 1 Anaemia in Ovarian Carcinoma 1

Interventions

Epoetin Alfa 49 Darbepoetin alfa 34 epoetin beta 12 ferric carboxymaltose 11 Cyclophosphamide 5 luspatercept 4 fludarabine phosphate 4 fludarabine 4 Erythropoietin 4 Cyclosporine 4 Cisplatin 4 Busulfan 4 Blood Transfusion 4 ACE-011 4 peginesatide 3 hematide 3 ferrous sulfate 3 ferric gluconate 3 Radiotherapy 3 Lenalidomide 3 Iron-Dextran Complex 3 Filgrastim 3 Biopsy 3 Antilymphocyte Serum 3 thymoglobulin 2 ruxolitinib 2 iron isomaltoside 1000 2 ferrous fumarate 2 continuous erythropoietin receptor activator 2 Thiotepa 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05407987 2025-04-25

FORGE II

AHS Cancer Control Alberta

Phase 3 Recruiting

Classical hematology

Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡